Effectiveness of levamisole in the treatment of patients with severe COVID-19: a randomized controlled clinical trial
Introduction: Inflammation plays a role in coronavirus disease 2019 (COVID-19) pathophysiology and anti-inflammatory drugs may help reduce the disease severity. Levamisole is an anthelmintic drug with immunomodulatory and possible antiviral effects. This study aimed to evaluate the role of levamiso...
Saved in:
| Main Authors: | Morteza Pourahmad, Rasool Soltani, Mohammad H Noroozi, Farzin Khorvash, Behrooz Ataei, Manijeh Shams, Fatemeh Nikokar |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
The Journal of Infection in Developing Countries
2024-12-01
|
| Series: | Journal of Infection in Developing Countries |
| Subjects: | |
| Online Access: | https://jidc.org/index.php/journal/article/view/18659 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Levamisole-induced leukoencephalopathy: a rare drug side effect
by: E. S. Yelshibayeva, et al.
Published: (2025-07-01) -
Vasculitis asociada al consumo de cocaína adulterada con levamisol
by: Guillermo González Rodríguez, et al.
Published: (2019-02-01) -
Can Levamisole be used in the treatment of COVID-19 patients presenting with diarrhea?
by: Oğuz Abdullah Uyaroğlu, et al.
Published: (2020-08-01) -
Comparison of Free and Liposomal Levamisole Antiparasitic Activity in Sheep
by: Mehmet Özüiçli, et al.
Published: (2025-04-01) -
Preparation of Pharmaceutical Formula of Rafoxanide and Levamisole 6% Suspension as Pilot Production
by: Ahmed Jasim Abbas, et al.
Published: (2021-06-01)